Development and Optimization of a Novel Lozenge Containing a Metronidazole-Peppermint Oil-Tranexamic Acid Self-Nanoemulsified Delivery System to Be Used after Dental Extraction: In Vitro Evaluation and In Vivo Appraisal

In-depth studies on essential oil-based nanoemulsions (NEs) have centered on a variety of oral health issues. NEs improve the delivery of nonpolar active agents to sites and thereby boost the dissolution and distribution of the agents. Metronidazole-peppermint oil-tranexamic acid self-nanoemulsifyin...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Alissa (Author), Ahmed Hjazi (Author), Ghadah S. Abusalim (Author), Ghfren S. Aloraini (Author), Suad A. Alghamdi (Author), Waleed Y. Rizg (Author), Khaled M. Hosny (Author), Jazia A. Alblowi (Author), Hanaa Alkharobi (Author)
Format: Book
Published: MDPI AG, 2023-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a9ec7c9371ff41e7a9550a6d7dc9eb4c
042 |a dc 
100 1 0 |a Mohammed Alissa  |e author 
700 1 0 |a Ahmed Hjazi  |e author 
700 1 0 |a Ghadah S. Abusalim  |e author 
700 1 0 |a Ghfren S. Aloraini  |e author 
700 1 0 |a Suad A. Alghamdi  |e author 
700 1 0 |a Waleed Y. Rizg  |e author 
700 1 0 |a Khaled M. Hosny  |e author 
700 1 0 |a Jazia A. Alblowi  |e author 
700 1 0 |a Hanaa Alkharobi  |e author 
245 0 0 |a Development and Optimization of a Novel Lozenge Containing a Metronidazole-Peppermint Oil-Tranexamic Acid Self-Nanoemulsified Delivery System to Be Used after Dental Extraction: In Vitro Evaluation and In Vivo Appraisal 
260 |b MDPI AG,   |c 2023-09-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics15092342 
500 |a 1999-4923 
520 |a In-depth studies on essential oil-based nanoemulsions (NEs) have centered on a variety of oral health issues. NEs improve the delivery of nonpolar active agents to sites and thereby boost the dissolution and distribution of the agents. Metronidazole-peppermint oil-tranexamic acid self-nanoemulsifying drug delivery systems (MZ-PO-TX-SNEDDS) were created and loaded into novel lozenges to act as antifungal, hemostatic, antimicrobial, and analgesic dosage forms after dental extractions. The design-of-experiments approach was used in creating them. To generate the NEs, different concentrations of MZ-PO (240, 180, and 120 mg), 2% TX (600, 450, and 300 mg), and S<sub>mix1:1</sub> (600, 400, and 200 mg) were used. The ideal formulation had serum levels of 1530 U/mL of interleukin-6, a minimal inhibitory concentration against bacteria of 1.5 µg/mL, a droplet size of 96 nm, and a blood coagulation time of 16.5 min. Moreover, the produced NE offered better MZ release. The adopted design was used to produce the ideal formulation; it contained 240 mg of MZ-PO, 600 mg of 2% TX, and 600 mg of S<sub>mix1:1.</sub> It was incorporated into lozenges with acceptable characteristics and an improved capability for drug release. These lozenges had reasonable coagulation times, IL-6 serum levels, and MIC values. All of these characteristics are desirable for managing symptoms following tooth extractions. Therefore, these lozenges loaded with MZ-PO-TX-SNEDDs might be considered a beneficial paradigm for relieving complications encountered after tooth extractions. 
546 |a EN 
690 |a metronidazole 
690 |a peppermint oil 
690 |a tranexamic acid 
690 |a nanoemulsion 
690 |a hemostatic 
690 |a optimization 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 15, Iss 9, p 2342 (2023) 
787 0 |n https://www.mdpi.com/1999-4923/15/9/2342 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/a9ec7c9371ff41e7a9550a6d7dc9eb4c  |z Connect to this object online.